While Mr. Trump ’s call to cut regulations has been warmly received by other industries , some biotech executives have reacted to his remarks with alarm .Those affiliated with some smaller companies have privately described the choice of Mr. O’Neill as a    scenario that could send the drug industry into chaos .The F. D. A. Mr. Trump say , is not perfect , but its standards provide a level playing field on which both big and small companies can compete ."